250 results on '"Correa-Rotter, Ricardo"'
Search Results
2. Mind the Gap in Kidney Care: Translating What We Know into What We Do
3. The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis
4. Dietary inflammatory index and low glomerular filtration rate in Mexican adults: A cross-sectional study
5. #294 Pragmatic literature reviews to populate a patient-level model to project the future clinical burden of CKD in low-and middle-income countries
6. #255 PaCE CKD: the impact of caregiving on health states and work productivity in chronic kidney disease: results from an international survey
7. #254 PaCE CKD: examining health status and financial burden in patients with chronic kidney disease: assessing the non-clinical burden of disease
8. Mind the gap in kidney care: translating what we know into what we do
9. Association between soft drinks intake and low glomerular filtration rate in Mexican adults: Results from RenMex
10. WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
11. WCN24-1464 MEASUREMENT OF CEREBRAL BLOOD FLOW USING TRANSCRANIAL DOPPLER ULTRASOUND: COMPARISON OF TWO POPULATIONS OF PATIENTS IN CHRONIC HEMODIALYSIS
12. WCN24-890 INSIDE CKD - PRAGMATIC LITERATURE REVIEWS TO POPULATE A PATIENT-LEVEL MODEL TO PROJECT THE FUTURE CLINICAL BURDEN OF CKD IN FOUR LOW- AND MIDDLE INCOME COUNTRIES
13. WCN24-1229 EFFECTS OF TREATMENT AND CLINICAL EVENTS ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A PRESPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL
14. Mind the gap in kidney care: translating what we know into what we do
15. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
16. New and emerging therapies for diabetic kidney disease
17. Global Disparities in Chronic Kidney Disease Clinical Trials: A Systematic Review
18. Advances in hemodialysis in the last decade in Latin America
19. Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex
20. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis
21. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
22. Ethnicity and Chronic Kidney Disease in Disadvantaged Populations—An International Perspective
23. List of Contributors
24. Guía mexicana de práctica clínica para el diagnóstico y tratamiento en pacientes adultos con diabetes tipo 2
25. Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
26. Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty
27. #2758 AMBIENT HEAT EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE TRAJECTORY: A POST-HOC ANALYSIS OF THE DAPA-CKD TRIAL
28. Conservative and Palliative Care in Old Age Individuals with End-Stage Renal Disease
29. Dapagliflozin and Anemia in Patients with Chronic Kidney Disease
30. Optimizing peritoneal dialysis initiation: A comparative cohort study of catheter placement methods for shortening break‐in periods
31. Effect of Kidney transplantation on cyst growth in autosomal dominant polycystic kidney disease
32. Acute kidney injury in critical care COVID-19 patients on invasive mechanical ventilation: the potential preventive role of dexamethasone
33. Unmet Needs of Chronic Kidney Disease in Latin America: A Review from Expert Virtual Working Group
34. Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
35. Efficacy of dapagliflozin by baseline diabetes medications: A prespecified analysis from the DAPA-CKD study
36. Efficacy of dapagliflozin by baseline diabetes medications: A prespecified analysis from the DAPA-CKD study
37. Inside Ckd: Projecting the Clinical Burden of Chronic Kidney Disease (Ckd) with Patient-Level Microsimulation Modelling
38. Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease
39. Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial
40. Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu
41. Utility of Estimated Glomerular Filtration Rate in Hypertensive and Type 2 Diabetic Patients: Results from a Community-Based Study
42. Consenso de la Sociedad Latinoamericana de Nefrología e Hipertensión en relación con el papel de los antagonistas del receptor mineralocorticoide en enfermedad renal crónica
43. Effects of Dapagliflozin in People without Diabetes and with Microalbuminuria
44. Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD
45. Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis
46. 423.9: The First 52 Global Kidney Exchange Transplants: Overcoming Multiple Barriers to Transplantation
47. Contributors
48. Mesoamerican Nephropathy or Chronic Kidney Disease of Unknown Origin
49. Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease
50. Sleep Quality After Intradialytic Oral Nutrition: A New Benefit of This Anabolic Strategy? A Pilot Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.